4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0001645041-16-000003
$BHCCIK 0000885590operating
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:40 PM ET
Size
4.9 KB
Accession
0001645041-16-000003
Insider Transaction Report
Form 4
Rosiello Robert L.
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock, no par value
2016-12-05$18.00/sh−14,687$264,366→ 517,683 total
Footnotes (1)
- [F1]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:40 PM ET
- Size
- 4.9 KB